In this study, only a few stemness genes, such as SOX2, TWIST1, and CD34, were aberrantly expressed [absolute fold change (FC) ≥ 2] in more than five cancer types (Figure S6C), indicating that integrins may function downstream of key stemness factors. Here, CD34 is linked to cancer.